Drugs / FVIII
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02727647 | May 2015 → Mar 2016 | hemophilia A | Chulalongkorn University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FVIII | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02727647 ↗ |
| Modality | Protein / enzyme biologic | “factor VIII concentrate dose” NCT02727647 ↗ |